Walter Jessen

Compandia Touts Bioinformatics as Differentiator in Biomarker Discovery Market

I'd love to try this out: Compandia recently launched it's third software tool called Pathway Distiller, which uses artificial neural networks (ANNs) to predict the interactions between biomarkers associated with a particular biomedical question.

Advancing the Use of Biomarkers in Cancer Drug Development

Sally Church highlights a consensus report by the AACR, FDA and NCI on advancing the use of biomarkers in cancer drug development.

How Does Web 2.0 Increase Life Science Product Sales?

Web 2.0 elements and more content in a life science company's web site = stronger user engagement = increased business and customer retention.

U.S. presses drugmakers on neglected disorders

It's surprising given the reduced development costs that drug repositioning isn't more enticing to big pharma. Perhaps that will change as more and more R&D work is outsourced to CROs.

The Quantity vs Quality Debate Revisited

To the majority of the world, numbers matter. However, having a large platform doesn’t mean you’re influential at all. You could have a million followers, but if no one replies to you, retweets you, comments on your blog, purchases your products, or emails you, then you aren’t getting much out of it. The internet world is transitioning from a place of mass communication, to a one-to-one conversations. This means that if you aren’t meeting people individually, you won’t achieve great business results.

Shared via Google Reader